Join us for our future of nonclinical and clinical trials event. 

Australia is an attractive destination for US and global biotech companies looking to accelerate their drug development pathway and grow their global presence.

But before you enter the Australian market, you need to know the tax and regulatory implications of doing business down under.

Don't miss this chance to get the insights you need to expedite your route to commercialisation. 

REGISTER TODAY »